Artificial intelligence technology shows promise in facilitating the analysis and interpretation of pathology images, which can benefit cancer patients through more precise diagnosis and potentially better targeted treatment options.
Open digital pathology environments can break down barriers to allow for rapid technology advances across industry and research partners, which is critical in developing next-generation diagnostic tests.
What is the Roche Digital Pathology Open Environment?
The Roche Digital Pathology Open Environment allows software developers to easily integrate their image analysis tools for tumor tissue with Roche’s Navify Digital Pathology enterprise software, an application for pathologist workflow. The Open Environment allows for the secure exchange and flow of data so that pathologists can access advanced algorithms from third parties alongside Roche’s menu of artificial intelligence-based image analysis tools. This enables software developers globally to distribute their digital products through Roche’s Navify Digital Pathology software, offering a broader set of diagnostic tools for pathologists and ultimately, the potential for better and faster answers for patients.
Innovation in Digital Pathology
Pathology is undergoing a transformation towards digitization. A workflow solution that can enable pathologists to efficiently complete their daily workload with easy access to new digital tools is essential.
As artificial intelligence tools for clinical use continue to develop, industry and research partners can now leverage Roche’s Digital Pathology Open Environment. This access expands the ability for pathologists to more easily read images from the VENTANA DP 600 slide scanner and the VENTANA DP 200 slide scanner1 for image analysis algorithm development.
Ultimately, innovative pathology imaging tools for laboratories and healthcare providers can support the selection of the most appropriate targeted therapy option for each patient, advancing Roche’s mission to deliver personalized healthcare.